Ms Donglei Mao, academic director and editor of "Medical Economic News", journalist; formerly chief editor and director of "China Prescription Drug" magazine. Member of (DIA, Drug Information Association) China Advisory Committee.
Focused on news reporting on pharmaceutical R&D, regulatory oversight and review, pharmaceutical and healthcare industry policies and regulations.
Highlights of my 13 years of media coverage on the pharmaceutical industry: :
-interviewed the last 5 directors of the China Center for Drug Evaluation(CDE), and the last head of registration of CFDA;
-Interviewed with more than 10 multinational pharmaceutical companies’ Asia-Pacific head of research and development, and the innovation-driven domestic drug companies;
-Interviewed with the heads of more than 10 domestic drug clinical trial centers;
-Interviewed with Paul Pmerantz, former DIA worldwide executive director;
-Interviewed with Dr Ling Su, former chairman of the DIA worldwide executive council;
-Interviewed with Nign Xu, Chairman of DIA Advisory Council of China;
-Reported and involved in the planning of the first, third, fourth, fifth DIA China Annual Meetings